CRYPTO:INJUSD

Injective Usd Stock News

etoro logo Buy INJUSD
*Your capital is at risk
$6.40
-0.110 (-1.69%)
At Close: Jun 03, 2026
The crypto market is showing strength in recovery in the second week of November, with Bitcoin climbing past $105,000. However, in addition to dependence on broader market cues, some altcoins are also
This week in crypto, several altcoins may be primed for significant moves, catalyzed by ecosystem-specific developments.
Injective Protocol shows bullish momentum signals with MACD histogram turning positive. Analysts target $7.38 short-term with potential $8+ if resistance breaks.
As the INJ price prediction 2025 draws new attention, Injective now trades in the critical $6–$7 multi-year support zone, a region that has repeatedly triggered strong reversals in its history. With
INJ price prediction points to $8.50-9.00 upside potential within 2 weeks as bullish MACD divergence and neutral RSI suggest recovery momentum from oversold conditions.
Injective, the blockchain project focused on decentralized finance (DeFi), has unveiled a no-code platform designed to let anyone build and deploy Web3 applications without writing a single line of co
The Injective ecosystem is seeing a surge in on-chain activity even as its native token struggles to keep pace. Total value locked (TVL) on Injective has jumped about 14% in the past 24 hours, accordi
The cryptocurrency market fell over 1% in the past 24 hours as bearish sentiment persisted despite positive macroeconomic developments. Markets also experienced volatility ahead of the upcoming FOMC m
Crypto.com has partnered with Pineapple Financial to provide custody and staking infrastructure for its INJ treasury, adding to its growing roster of institutional custody clients. Crypto.com and NYSE
TL;DR 21Shares has filed for an Injective (INJ) ETF, aiming to capture growing institutional interest in the project. The ETF would allow exposure to INJ without managing wallets or private keys, keep
21Shares on Monday filed with the U.S. SEC for an Injective ETF, the second INJ exchange-traded fund in development after Canary Capital's July application.
Injective trades at $8.73 down 2.2% as revolutionary perpetual futures for private equity markets launch amid Bitcoin's retreat from $110K highs, testing critical technical levels.
21Shares ETF Filing Shows Rising Institutional Activity and Liquidity in Injective (INJ)
The filing underscores the increasing integration of digital assets into mainstream finance, enhancing accessibility for institutional investors. 21Shares files for Injective ETF amid growing institut
Injective (INJ) climbs to $8.84 with 5.7% daily gains as RSI suggests potential bounce from oversold conditions, though price remains below key moving averages.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE